Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)

INTRODUCTION: Etanercept (ETN) has been shown to slow radiographic progression of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in clinical trials. This real-world, non-interventional study assessed radiographic progression in patients with RA or PsA treated with ETN for ≤ 36 months in out...

Descripción completa

Detalles Bibliográficos
Autores principales: Wassenberg, Siegfried, Rau, Rolf, Klopsch, Thilo, Plenske, Anja, Jobst, Jürgen, Klaus, Pascal, Meng, Thomas, Löschmann, Peter-Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931988/
https://www.ncbi.nlm.nih.gov/pubmed/36251174
http://dx.doi.org/10.1007/s40744-022-00491-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931988/
https://www.ncbi.nlm.nih.gov/pubmed/36251174
http://dx.doi.org/10.1007/s40744-022-00491-4

Ejemplares similares